MoneyWorks4Me

Beryl Drugs - Quaterly Results

12 Aug 2026 Evaluate
The turnover for the June 2026 quarter moved up 56.47% to Rs. 75.67 millions as compared to Rs. 48.36 millions during the year-ago period.Net Profit witnessed a 1005.00% growth almost the double from Rs. 0.20 millions to Rs. 2.21  millions  of same quarter last year.Operating profit surged to 6.48 millions from the corresponding previous quarter of 5.51 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 75.67 48.36 56.47 75.67 48.36 56.47 193.10 225.55 -14.39
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 6.48 5.51 17.60 6.48 5.51 17.60 24.25 26.46 -8.35
Interest 0.62 1.01 -38.61 0.62 1.01 -38.61 3.44 5.34 -35.58
PBDT 5.86 4.50 30.22 5.86 4.50 30.22 20.81 21.12 -1.47
Depreciation 3.16 3.81 -17.06 3.16 3.81 -17.06 14.93 12.57 18.77
PBT 2.70 0.69 291.30 2.70 0.69 291.30 5.88 8.55 -31.23
TAX 0.49 0.49 0.00 0.49 0.49 0.00 1.63 2.87 -43.21
Deferred Tax 0.36 -1.01 -135.64 0.36 -1.01 -135.64 0.49 0.97 -49.48
PAT 2.21 0.20 1005.00 2.21 0.20 1005.00 4.25 5.68 -25.18
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 8.56 11.39 -24.84 8.56 11.39 -24.84 12.56 11.73 7.05
Peers
Company Name CMP
Sun Pharma. Inds. 1846.45
Dr. Reddys Labs. 1212.60
Cipla 1370.90
Lupin 2122.40
Zydus Lifesciences 1172.70
View more..